Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant

International Journal of Pharmaceutics

Volumn 447, Issue 1-2, 2013, Pages 22-30

  Guo, Lei ^a,b   Chen, Jianmin ^a,b   Qiu, Yuqin ^a   Zhang, Suohui ^a   Xu, Bai ^a   Gao, Yunhua ^a  

^a TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Dissolving polyvinylpyrrolidone microneedles; Liposome encapsulated antigen and adjuvant; Transcutaneous immunization

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A; LIPOSOME; OVALBUMIN; POVIDONE;

ANIMAL EXPERIMENT; ARTICLE; DISSOLUTION; DRUG STABILITY; FEMALE; IMMUNIZATION; LIPOSOMAL DELIVERY; MICRONEEDLE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TH1 TH2 BALANCE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIGENS; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; LIPOSOMES; MICE; MICE, INBRED BALB C; MICROINJECTIONS; NEEDLES; OLIGODEOXYRIBONUCLEOTIDES; OVALBUMIN; PARTICLE SIZE; SOLUBILITY; SWINE;

EID: 84874934017     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.02.006     Document Type: Article

References (38)

1. J.C. Aguilar, and E.G. Rodriguez Vaccine adjuvants revisited Vaccine 25 2007 3752 3762
2. S.M. Bal, Z. Ding, E.V. Riet, W. Jiskoot, and J.A. Bouwstra Advances in transcutaneous vaccine delivery: do all ways lead to Rome? J. Control. Release 148 2010 266 282
3. D. Christensen, E.M. Agger, L.V. Andreasen, D. Kirby, P. Andersen, and Y. Perrie Liposome-based cationic adjuvant formulations (CAF): past, present, and future J. Liposome Res. 19 2009 2 11
4. R.S. Chu, O.S. Targoni, A.M. Krieg, P.V. Lehmann, and C.V. Harding CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity J. Exp. Med. 186 1997 1623 1631
5. R.L. Coffman, D.A. Lebman, and P. Rothman Mechanism and regulation of immunoglobulin isotype switching Adv. Immunol. 54 1993 229 270
6. P.C. DeMuth, J.J. Moon, H. Suh, P.T. Hammond, and D.J. Irvine Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery ACS Nano 6 2012 8041 8051
7. S. Henry, D.V. McAllister, M.G. Allen, and M.R. Prausnitz Microfabricated microneedles: a novel approach to transdermal drug delivery J. Pharm. Sci. 87 1998 922 925
8. M.R. Jaafari, A. Badiee, A. Khamesipour, A. Samiei, D. Soroush, M. Tavassoti, F. Barkhordari, W.R. Mcmasterd, and F. Mahboudi The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome Vaccine 25 2007 6107 6117
9. C.J. Ke, Y.J. Lin, Y.C. Hu, W.L. Chiang, K.J. Chen, W.C. Yang, H.L. Liu, C.C. Fu, and H.W. Sung Multidrug release based on microneedle arrays filled with pH-responsive PLGA hollow microspheres Biomaterials 33 2012 5156 5165
10. G.F. Kersten, and D.J. Crommelin Liposomes and ISCOMs Vaccine 21 2003 915 920
11. D.J. Kirby, I. Rosenkrands, E.M. Agger, P. Andersen, A.G.A. Coombes, and Y. Perrie Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres J. Drug Target. 16 2008 543 554
12. Y.C. Kim, J.H. Park, and M.R. Prausnitz Microneedles for drug and vaccine delivery Adv. Drug Deliv. Rev. 64 2012 1547 1568
13. E.E. Kis, G. Winter, and J. Myschik Devices for intradermal vaccination Vaccine 30 2012 523 538
14. D.M. Klinman, D. Currie, I. Gurse, and D. Verthelyi Use of CpG oligodeoxynucleotides as immune adjuvants Immunol. Rev. 199 2004 201 216
15. D.G. Koutsonanos, M.P. Martin, V.G. Zarnitsyn, S.P. Sullivan, R.W. Compans, M.R. Prausnitz, and I. Skountzou Transdermal influenza immunization with vaccine-coated microneedle arrays Transdermal Vaccination 4 2009 47 73
16. A.M. Krieg CpG motif in bacterial DNA and their immune effects Annu. Rev. Immunol. 20 2002 709 760
17. T.S. Kupper, and R.C. Fuhlbrigger Immune surveillance in the skin: mechanisms and clinical consequences Nat. Rev. 4 2004 211 222
18. E.C. Lavelle, M.K. Yeh, A.G. Commbes, and S.S. Davis The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol Vaccine 17 1999 512 529
19. G.H. Li, A. Badkar, S. Nema, C.S. Kolli, and A.K. Banga In vitro transdermal delivery of therapeutic antibodies using maltose microneedles Int. J. Pharm. 388 2009 109 115
20. N. Li, L.H. Peng, X. Chen, S. Nakagawa, and J.Q. Gao Effective transcutaneous immunization by antigen-loaded fexible liposome in vivo Int. J. Nanomed. 6 2011 3241 3250
21. S. Li, Y.Q. Qiu, S.H. Zhang, and Y.H. Gao Enhanced transdermal delivery of 18β-glycyrrhetic acid via elastic vesicles: in vitro and in vivo evaluation Drug Dev. Ind. Pharm. 35 2012 1 11
22. W.Z. Li, M.R. Huo, J.P. Zhou, Y.Q. Zhou, B.H. Hao, T. Liu, and Y. Zhang Super-short solid silicon microneedles for transdermal drug delivery applications Int. J. Pharm. 89 2010 122 129
23. K. Maaden, W. Jiskoot, and J. Bouwstra Microneedle technologies for (trans) dermal drug and vaccine delivery J. Control. Release 161 2012 645 655
24. K. Matsuo, Y. Yokota, Y. Zhai, Y.S. Quan, F. Kamiyama, Y. Mukai, N. Okada, and S. Nakagawa A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens J. Control. Release 161 2012 10 17
25. D. Mishra, V. Dubey, A. Asthana, A.K. Saraf, and N.K. Jain Elastic liposomes mediated transcutaneous immunization against Hepatitis B Vaccine 24 2004 4847 4855
26. R.E. Morton, and T.A. Evans Modification of the bicinchoninicacid protein assay to eliminate lipid interference in determining lipoprotein protein content Anal. Biochem. 204 1992 332 334
27. A. Naik, Y.N. Kalia, and R.H. Guy Transdermal drug delivery: overcoming the skin's barrier function Pharm. Sci. Tech. Today 3 2000 318 326
28. T. Nakanishi, J. Kunisawa, A. Hayashi, Y. Tsutsumi, K. Kubo, S. Nakagawa, M. Nakanishi, K. Tanaka, and T. Mayumi Positively charged liposome functions as an efficient immunoadjuvant in inducing cellmediated immune response to soluble proteins J. Control. Release 61 1999 233 240
29. Y. Perrie, A.R. Mohammed, D.J. Kirby, S.E. McNeil, and V.W. Bramwell Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens Int. J. Pharm. 364 2008 272 280
30. M.R. Prausnitz Microneedles for transdermal drug delivery Adv. Drug Deliv. Rev. 56 2004 581 587
31. F.S. Quan, Y.C. Kim, R.W. Compans, M.R. Prausnitz, and S.M. Kang Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles J. Control. Release 147 2010 326 332
32. N. Romani, B.E. Clausen, and P. Stoitzne r Langerhans cells andmore: langerin-expressing dendritic cell subsets in the skin Immunol. Rev. 234 2010 120 141
33. S. Saraf, D. Mishra, A. Asthana, R. Jain, S. Singh, and N.K. Jain Lipid microparticles for mucosal immunization against Hepatitis B Vaccine 2006 2445 2456
34. B. Slütter, S.M. Bal, Z. Ding, W. Jiskoot, and J.A. Bouwstra Adjuvant effect of cationic liposomes and CpG depends on administration route J. Control. Release 154 2011 123 130
35. S.P. Sullivan, N. Murthy, and M.R. Prausnitz Minimally invasive protein delivery with rapidly dissolving polymer microneedles Adv. Mater. 20 2008 933 938
36. S.P. Sullivan, D.G. Koutsonanos, M.P. Martin, J.W. Lee, V. Zarnitsyn, N. Murthy, R.W. Compans, L. Akountzou, and M.R. Prausnitz Dissolving polymer microneedle patches for influenza vaccination Nat. Med. 16 2010 915 920
37. L. Thiele, J.E. Diederichs, R. Reszka, H.P. Merkle, and E. Walter Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells Biomaterials 24 2003 1409 1418
38. R.D. Weeratna, C.L.B. Millan, M.J. McCluski, and H.L. Davis CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice FEMS Immunol. Med. Microbiol. 32 2001 65 71